Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for MolPort-001-785-627

    Client Email Product

    MolPort-001-785-627

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    6
    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    6
    API REF. PRICE (USD / KG)
    1

    API Market Place

    3
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    3
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    1
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    18
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    7
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Polyplastics announces commercial availability of DURACON POM PM Series
    Polyplastics announces commercial availability of DURACON POM PM Series

    https://www.indianpharmapost.com/news/polyplastics-announces-commercial-availability-of-duracon-pom-pm-series-for-medical-industry-14311

    INDIANPHARMAPOST
    22 Jun 2023
    Share Share
    Be EPIC: USU Extension Explains Vaping Prevention, Dangers
    Be EPIC: USU Extension Explains Vaping Prevention, Dangers

    https://etvnews.com/be-epic-usu-extension-explains-vaping-prevention-dangers/

    Julie Johansen ETVNEWS
    05 Nov 2022
    Share Share
    Seneca Announces Novel SVV-001 Patient Screening Test For SVV-001 Therapy
    Seneca Announces Novel SVV-001 Patient Screening Test For SVV-001 Therapy

    https://www.businesswire.com/news/home/20210914005102/en

    BUSINESSWIRE
    14 Sep 2021
    Share Share
    Novartis chalks up another phase 3 asthma win as approval nears
    Novartis chalks up another phase 3 asthma win as approval nears

    https://www.fiercebiotech.com/biotech/novartis-chalks-up-another-phase-3-asthma-win-as-approval-nears

    Nick Paul Taylor FIERCE BIOTECH
    01 Oct 2019
    Share Share
    U.S. tests find low cancer risk from Lumber Liquidators' flooring
    U.S. tests find low cancer risk from Lumber Liquidators' flooring

    http://www.reuters.com/article/us-lumberliquidators-health-idUSKCN0VJ21Y

    REUTERS
    10 Feb 2016
    Share Share
    Bill to regulate e-cigarettes clears California legislative hurdle
    Bill to regulate e-cigarettes clears California legislative hurdle

    http://in.reuters.com/article/2015/08/27/us-usa-california-ecigarettes-idINKCN0QW2HQ20150827

    SHARON BERNSTEIN REUTERS
    27 Aug 2015
    Share Share
    The Jonas Salk Polio Vaccine: A Medical Breakthrough or a Propaganda Campaign for Big Pharma?
    The Jonas Salk Polio Vaccine: A Medical Breakthrough or a Propaganda Campaign for Big Pharma?

    http://www.globalresearch.ca/the-jonas-salk-polio-vaccine-a-medical-breakthrough-or-a-propaganda-campaign-for-big-pharma/5433687

    Timothy Alexander Guzman GLOBAL RESEARCH
    25 Feb 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search